MaxCyte, Inc. (MXCT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:39PM EDT. Market open.
| Previous close | 4.7300 |
| Open | 4.7000 |
| Bid | 4.7000 x 200 |
| Ask | 4.7800 x 100 |
| Day's range | 4.6000 - 4.7850 |
| 52-week range | 2.4500 - 5.5450 |
| Volume | |
| Avg. volume | 596,191 |
| Market cap | 515.663M |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3700 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 9.25 |
- GuruFocus.com
MaxCyte Inc (MXCT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...
Discover how MaxCyte Inc (MXCT) achieved significant revenue increases and strategic advancements in the first quarter of 2024.
ZacksMaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
MaxCyte (MXCT) delivered earnings and revenue surprises of 35.71% and 46.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.